Latest Announcements

BSE & NSE corporate filings with AI summaries

NSECopy of Newspaper PublicationResults3 Sept 2026

Sansera Engineering Limited

Copy of Newspaper Publication

Sansera Engineering Limited has informed the Exchange about the dispatch of Annual Report 2025-26 and notice of 44th Annual General Meeting (AGM) through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The AGM will be held on September 24, 2026, and the Register of Members and Share Transfer Books will be closed from September 18, 2026, to September 24, 2026, for the purpose of AGM and payment of dividend.

Read more →📎 1 attachment
NSEESOP/ESOS/ESPSesop3 Sept 2026

Coforge Limited

ESOP/ESOS/ESPS

Coforge Limited has informed the Exchange regarding the allotment of 57,598 shares under the ESOP Scheme of the Company, increasing the paid-up share capital to 44,29,78,090 equity shares.

Read more →📎 1 attachment
BSEOthersResults3 Sept 2026

Mansoon Trading Company Ltd

Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015 we submit herewith 41st Annual Report of the Company for the financial year 2025-26

Mansoon Trading Company Ltd submitted its 41st Annual Report for the financial year 2025-26, as per Regulation 34 of SEBI (LODR) Regulations, 2015. The report includes the audited financial statements, reports of the board and auditor, and notice of the 41st Annual General Meeting.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion3 Sept 2026

Suven Life Sciences Ltd

Please find enclosed the News release

Suven Life Sciences Ltd announced the completion of patient enrollment in its global Phase-3 clinical study of Masupirdine for the treatment of Agitation associated with Alzheimer's Dementia (AAD). The study was designed to randomize approximately 375 patients, but a total of 424 patients were randomized. The Last patient last visit (LPLV) is expected by end of December 2026, and topline results are expected by May 2027.

Read more →📎 1 attachment
NSEPress Release▲ PositiveProduct Launch3 Sept 2026

Suven Life Sciences Limited

Press Release

Suven Life Sciences has completed patient enrollment in its global Phase-3 clinical study of Masupirdine for the treatment of Agitation associated with Alzheimer's Dementia (AAD). The study was designed to randomize 375 patients, but 424 patients were enrolled. The Last Patient Last Visit (LPLV) is expected by end of December 2026, and Topline results are expected by May 2027.

Read more →📎 1 attachment
BSEAGM/EGMResults3 Sept 2026

JK Paper Ltd

Shareholders Meeting- Scrutinizer''s Report

JK Paper Ltd has announced the voting results of its 65th Annual General Meeting (AGM), where all resolutions were passed with requisite majority. The company also declared a final dividend of Rs. 4/- per equity share for the financial year ended 31st March 2026.

Read more →📎 1 attachment
← PreviousPage 3385 of 8641Next →